Assessment of diabetic retinopathy by measuring retina-specific mRNA in blood.

about

Effects of insufficient sleep on circadian rhythmicity and expression amplitude of the human blood transcriptome Circulating Biomarkers of Diabetic Retinopathy: An Overview Based on Physiopathology

P2860

Q23761158-C498AF1D-4CAE-4C2F-9152-5FD164372F58 Q26744760-A911150E-A4CA-43CA-B95C-202BCB6EC494

P2860

Assessment of diabetic retinopathy by measuring retina-specific mRNA in blood.

Item

http://www.wikidata.org/entity/Q49177421

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Assessment of diabetic retinopathy by measuring retina-specific mRNA in blood.

@en

Assessment of diabetic retinopathy by measuring retina-specific mRNA in blood.

@nl

type

Item

label

Assessment of diabetic retinopathy by measuring retina-specific mRNA in blood.

@en

Assessment of diabetic retinopathy by measuring retina-specific mRNA in blood.

@nl

prefLabel

Assessment of diabetic retinopathy by measuring retina-specific mRNA in blood.

@en

Assessment of diabetic retinopathy by measuring retina-specific mRNA in blood.

@nl

P1476

Assessment of diabetic retinopathy by measuring retina-specific mRNA in blood.

@en

P2093

A Butt

http://www.w3.org/2001/XMLSchema#string

J Powrie

http://www.w3.org/2001/XMLSchema#string

M S Ahmad

http://www.w3.org/2001/XMLSchema#string

R Swaminathan

http://www.w3.org/2001/XMLSchema#string

P2860

Human retina-specific amine oxidase (RAO): cDNA cloning, tissue expression, and chromosomal mapping

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays

Screening and prevention of diabetic blindness.

Illegitimate transcription: transcription of any gene in any cell type

Measurement of thyroglobulin mRNA in peripheral blood as an adjunctive test for monitoring thyroid cancer

Circulating nucleic acids in plasma and serum as a noninvasive investigation for cancer: time for large-scale clinical studies?

Grading and disease management in national screening for diabetic retinopathy in England and Wales.

The impact of national diabetic retinopathy screening on ophthalmology: the need for urgent planning.

P304

S79-84

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14712598.2012.688947

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

12 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22594562

http://www.w3.org/2001/XMLSchema#string

Assessment of diabetic retinopathy by measuring retina-specific mRNA in blood.

about

P2860

P2860

Assessment of diabetic retinopathy by measuring retina-specific mRNA in blood.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698